Repatha
-
Pricey Cholesterol Drug From Amgen Reduces Heart Risks, Could Cost $14000
-
Amgen Cholesterol Drug Repatha Turned Down By UK Cost Watchdog
-
New Cholesterol Drugs Are Too Expensive: Independent Study Concludes
-
FDA Approval Of Repatha Cholesterol Drug A Big Win For Amgen
-
FDA Gives Nod To Praluent: New Class Of Cholesterol-Lowering Drug Is Pricey
-
Amgen Cholesterol Lowering Drug Repatha Receives EU Approval
-
FDA Panel Pushes For Approval Of Amgen's Cholesterol-Lowering Drug Repatha
-
Two Powerful Cholesterol Drugs May Be Approved By Summer
Most Popular
